Difference between revisions of "Template:Cannabinoids"
Jump to navigation
Jump to search
imported>Paine Ellsworth m (Redirect bypass from CUMYL-5F-P7AICA to 5F-CUMYL-P7AICA using popups) |
imported>Meodipt |
||
| (19 intermediate revisions by 4 users not shown) | |||
| Line 27: | Line 27: | ||
* [[Serinolamide A]] | * [[Serinolamide A]] | ||
* [[Tetrahydrocannabinol|THC]] | * [[Tetrahydrocannabinol|THC]] | ||
| − | * [[Tetrahydrocannabinol-C4| | + | * [[Tetrahydrocannabinol-C4|THCB]] |
* [[Tetrahydrocannabinolic acid|THCA]] | * [[Tetrahydrocannabinolic acid|THCA]] | ||
| + | * [[Tetrahydrocannabiphorol|THCP]] | ||
* [[Tetrahydrocannabivarin|THCV]] | * [[Tetrahydrocannabivarin|THCV]] | ||
* [[Yangonin]] | * [[Yangonin]] | ||
| Line 76: | Line 77: | ||
* [[AM-2389]] | * [[AM-2389]] | ||
* [[AM-4030]] | * [[AM-4030]] | ||
| + | * [[AM-7438]] | ||
* [[AMG-1]] | * [[AMG-1]] | ||
* [[AMG-3]] | * [[AMG-3]] | ||
| Line 243: | Line 245: | ||
| list9 = | | list9 = | ||
* [[5F-ADBICA]] | * [[5F-ADBICA]] | ||
| + | * [[5F-EDMB-PICA]] | ||
| + | * [[5F-MDMB-PICA]] | ||
* [[5F-NNE1]] | * [[5F-NNE1]] | ||
* [[5F-PCN]] | * [[5F-PCN]] | ||
| Line 256: | Line 260: | ||
* [[FDU-NNE1]] | * [[FDU-NNE1]] | ||
* [[MDMB-CHMICA]] | * [[MDMB-CHMICA]] | ||
| + | * [[MMB-CHMICA]] | ||
* [[MMB-2201]] | * [[MMB-2201]] | ||
* [[MN-25]] (UR-12) | * [[MN-25]] (UR-12) | ||
| Line 287: | Line 292: | ||
| group12 = Indazole-3-<br />carboxamides | | group12 = Indazole-3-<br />carboxamides | ||
| list12 = | | list12 = | ||
| + | * [[4F-MDMB-BINACA]] | ||
* [[5Cl-APINACA]] | * [[5Cl-APINACA]] | ||
* [[5F-ADB]] | * [[5F-ADB]] | ||
| Line 293: | Line 299: | ||
* [[5F-APINACA]] | * [[5F-APINACA]] | ||
* [[5F-CUMYL-PINACA]] | * [[5F-CUMYL-PINACA]] | ||
| + | * [[5F-EDMB-PINACA]] | ||
* [[5F-EMB-PINACA]] | * [[5F-EMB-PINACA]] | ||
* [[AB-CHMINACA]] | * [[AB-CHMINACA]] | ||
| Line 308: | Line 315: | ||
* [[APP-FUBINACA]] | * [[APP-FUBINACA]] | ||
* [[CUMYL-4CN-BINACA]] | * [[CUMYL-4CN-BINACA]] | ||
| + | * [[CUMYL-CBMINACA]] | ||
* [[CUMYL-PINACA]] | * [[CUMYL-PINACA]] | ||
* [[CUMYL-THPINACA]] | * [[CUMYL-THPINACA]] | ||
* [[EMB-FUBINACA]] | * [[EMB-FUBINACA]] | ||
* [[FUB-APINACA]] | * [[FUB-APINACA]] | ||
| + | * [[MDMB-4en-PINACA]] | ||
* [[MDMB-FUBINACA]] | * [[MDMB-FUBINACA]] | ||
* [[MDMB-CHMINACA]] | * [[MDMB-CHMINACA]] | ||
| Line 350: | Line 359: | ||
| group17 = Others | | group17 = Others | ||
| list17 = | | list17 = | ||
| + | * [[2F-QMPSB]] | ||
* [[4-HTMPIPO]] | * [[4-HTMPIPO]] | ||
* [[5F-PY-PICA]] | * [[5F-PY-PICA]] | ||
* [[5F-PY-PINACA]] | * [[5F-PY-PINACA]] | ||
* [[5F-3-pyridinoylindole]] | * [[5F-3-pyridinoylindole]] | ||
| + | * [[5F-CUMYL-P7AICA]] | ||
| + | * [[5F-CUMYL-PEGACLONE]] | ||
* [[A-836,339]] | * [[A-836,339]] | ||
* [[A-955,840]] | * [[A-955,840]] | ||
| Line 362: | Line 374: | ||
* [[AM-1714]] | * [[AM-1714]] | ||
* [[AZ-11713908]] | * [[AZ-11713908]] | ||
| + | * [[AZD-1940]] | ||
* [[BAY 38-7271]] | * [[BAY 38-7271]] | ||
* [[BAY 59-3074]] | * [[BAY 59-3074]] | ||
| Line 369: | Line 382: | ||
* [[CBS-0550]] | * [[CBS-0550]] | ||
* [[CUMYL-4CN-B7AICA]] | * [[CUMYL-4CN-B7AICA]] | ||
| − | * [[ | + | * [[CUMYL-CB-MEGACLONE]] |
| + | * [[CUMYL-CH-MEGACLONE]] | ||
* [[CUMYL-PEGACLONE]] | * [[CUMYL-PEGACLONE]] | ||
| + | * [[EG-018]] | ||
* [[FUBIMINA]] | * [[FUBIMINA]] | ||
* [[GSK-554,418A]] | * [[GSK-554,418A]] | ||
| Line 378: | Line 393: | ||
* [[LBP-1 (drug)|LBP-1]] | * [[LBP-1 (drug)|LBP-1]] | ||
* [[Leelamine]] | * [[Leelamine]] | ||
| + | * [[MCHB-1]] | ||
* [[MDA-7]] | * [[MDA-7]] | ||
* [[MDA-19]] | * [[MDA-19]] | ||
| Line 394: | Line 410: | ||
* [[PTI-1]] | * [[PTI-1]] | ||
* [[PTI-2]] | * [[PTI-2]] | ||
| + | * [[PTI-3]] | ||
* [[QMPSB]] | * [[QMPSB]] | ||
* [[S-444,823]] | * [[S-444,823]] | ||
| Line 450: | Line 467: | ||
| group7 = [[Cannabinoid receptor antagonist|Anticannabinoid]]s<br /><small>(antagonists/inverse<br />agonists/antibodies)</small> | | group7 = [[Cannabinoid receptor antagonist|Anticannabinoid]]s<br /><small>(antagonists/inverse<br />agonists/antibodies)</small> | ||
| list7 = | | list7 = | ||
| − | * [[ | + | * [[AM-251 (drug)|AM-251]] |
* [[AM281|AM-281]] | * [[AM281|AM-281]] | ||
* [[AM-630]] | * [[AM-630]] | ||
| Line 500: | Line 517: | ||
}}<noinclude> | }}<noinclude> | ||
| − | {{ | + | {{Documentation}} |
| − | |||
| − | |||
</noinclude> | </noinclude> | ||
Latest revision as of 09:52, 27 October 2020
Initial visibility: currently defaults to collapsed
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Cannabinoids|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Cannabinoids|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Cannabinoids|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to collapsed.
| The above documentation is transcluded from Template:Cannabinoids/doc. (edit | history) Editors can experiment in this template's sandbox (create | mirror) and testcases (create) pages. Please add categories to the /doc subpage. Subpages of this template. |